Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Lung Function, Heart Function and Aerobic Capacity in Patients Suffering From Long-term Symptoms Following SARS-CoV2-infection, and the Association With DNA Methylation

NCT04859894 is registered in ClinicalTrials.gov with Linkoeping University as lead sponsor.

NCT NCT04859894
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04859894 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Lung Function, Heart Function and Aerobic Capacity in Patients Suffering From Long-term Symptoms Following SARS-CoV2-infection, and the Association With DNA Methylation
Lead sponsor
Linkoeping University
Phase
Observational
Overall status
Unknown status
Start date
April 20, 2021
Completion date
June 30, 2022
Enrollment
150 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cardiopulmonary disease, covid19, dyspnea, epigenetic disorder, lung function decreased